Supernus Pharmaceuticals
SUPN
#4485
Rank
A$3.59 B
Marketcap
A$61.95
Share price
0.00%
Change (1 day)
24.70%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: A$3.59 Billion

As of June 2026 Supernus Pharmaceuticals has a market cap of A$3.59 Billion. This makes Supernus Pharmaceuticals the world's 4485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.59 B-18.55%
2025A$4.41 B33.75%
2024A$3.30 B42.23%
2023A$2.32 B-18.1%
2022A$2.83 B32.47%
2021A$2.13 B23.65%
2020A$1.72 B-2.8%
2019A$1.77 B-27.86%
2018A$2.46 B-5.72%
2017A$2.61 B50.79%
2016A$1.73 B91.94%
2015A$0.90 B107.44%
2014A$0.43 B28.95%
2013A$0.33 B59.97%
2012A$0.21 B

End of Day market cap according to different sources

On Jun 17th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

A$3.59 Billion
by Nasdaq info icon info icon
A$3.59 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$801.45 B 22,188.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$219.14 B 5,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.409 T 39,104.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$160.47 B 4,362.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
A$2.13 B-40.69%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$33.27 B 825.45%๐Ÿ‡บ๐Ÿ‡ธ USA